Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
about
A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemiaMolecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologyPrognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisMolecular Genetic Markers in Acute Myeloid LeukemiaPediatric AML: From Biology to Clinical ManagementMolecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcomeStem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.The genomic landscape of core-binding factor acute myeloid leukemiasA subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasPrognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in miceHOX deregulation in acute myeloid leukemiaAdvances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaIntegrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaGemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia.Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.HOX expression patterns identify a common signature for favorable AML.Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysisClinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.Tetraspanins Function as Regulators of Cellular Signaling.The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Pediatric acute myeloid leukemia.Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemiaNovel therapies for children with acute myeloid leukaemia.Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.The use of molecular genetics to refine prognosis in acute myeloid leukemia.How I treat paediatric relapsed acute myeloid leukaemia.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.
P2860
Q24685013-CD84615B-E515-411A-AE4A-F9B67CDF142CQ24685914-948D02EC-BB7F-425B-B053-02BC55B52A8DQ26771740-9056326F-BA27-413A-8BD6-716F940868F6Q26799606-2E2E29A5-60A7-4005-B0E9-5C116CA45751Q26799773-4D24F3B7-4B1C-456F-BF2B-175BD50E3B7CQ30252938-ABDE7EA0-EC97-441D-8946-BA85A689987FQ33431360-2DF07725-F584-42EB-BC87-763133127369Q33667247-D8937BA2-FEB6-408E-AEC6-14B96D3E43B8Q33697376-4143212D-2CFB-4930-92C9-FA7CEDB906DDQ33754603-458074BC-E741-4861-AA81-EA0DB8B944F1Q33901968-89551C4B-8381-41CB-BD49-BB5485083D28Q34036409-5092BE8F-DCEE-41F8-B40D-B8A022E9D4ABQ34169601-100AAA83-DC35-475F-8FFC-61D78A6CA66BQ34273628-284AC976-524C-411D-9F94-1DE991E0A8DBQ34572894-7DAD6F5A-7DD9-4617-9685-EBF4949B5DCCQ34578326-07F063E6-8828-4AEE-8B0D-4ACBF392C895Q34598109-04EF6076-4632-4A04-BE88-7D1AD83A908DQ35265916-BA6E2920-CBC1-46CE-9F8E-0BF872E3FDC5Q35606252-A7499388-27D9-4081-9515-D50449D6E2A5Q35807869-5B75E29C-7EA3-4D63-8E25-5CF6AE945D10Q36053792-CBB264E7-957A-46EE-8163-027D69305F54Q36222022-C8B1D3D2-C8C0-4130-8204-1236B513298AQ36591388-383EF928-92F8-428D-9F0E-8524AFCAF19FQ37176769-2A14AA49-DFE8-4636-AD1D-4F9D5B7BA933Q37301320-AE022FD0-6C76-469F-BAA4-82C676186A56Q37313002-2A931735-8EB5-442A-9A31-C21FD7D937EFQ37659087-6F1418C6-34C3-4FF1-B91D-FE04F3295566Q37679748-2A10F0E4-AC62-4D30-8100-470ACB4DEE10Q37739091-B7B63D25-14FF-4AC5-BF9C-AB4CB9453E95Q37874929-641FA5FB-120F-4D07-948B-C53B62F644D4Q37988570-2C168AE2-9BF5-4107-84BF-AF6DAD0977A6Q37992835-4D8467A1-A8E7-40FF-AE76-66088271CD75Q38068816-F958406F-D7DD-4B66-ADE2-C1D9F8C0EBBFQ38096798-5DEC3ADB-D7B7-440E-87F6-D9FD5C1C97D1Q38110527-D26505B1-F07B-4F70-9AF1-FF459D39C1A7Q38196743-55F1EE8B-FC31-4197-BA46-BD847A724D23Q38198569-158FCF38-52FF-4CA3-A174-865F92420CDFQ38212509-DB0A4264-5838-4554-AE8E-AA173C786C39Q38239675-74042637-DE48-4DB0-B1B2-21FE5695003EQ38263126-9C82C115-8C2C-439A-AC28-90E8A30CA96E
P2860
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mutations in KIT and RAS are f ...... factor acute myeloid leukemia.
@en
type
label
Mutations in KIT and RAS are f ...... factor acute myeloid leukemia.
@en
prefLabel
Mutations in KIT and RAS are f ...... factor acute myeloid leukemia.
@en
P2093
P2860
P356
P1433
P1476
Mutations in KIT and RAS are f ...... factor acute myeloid leukemia.
@en
P2093
Creutzig U
Goemans BF
Heinrich MC
Kaspers GJ
Meshinchi S
Reinhardt D
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403870
P577
2005-09-01T00:00:00Z
P5875
P6179
1033700089